Ashish Kacholia portfolio: Fineotex Chemical share worth rallied over 2% on Friday after a promoter purchased further shares within the specialty chemical substances firm. The ace investor Ashish Kacholia-portfolio inventory, Fineotex Chemical shares gained as a lot as 2.6% to ₹244.45 apiece on the BSE.
Fineotex Chemical is a producer of speciality chemical substances and enzymes for varied sectors together with textile, leather-based, development, water remedy, and extra.
In a regulatory submitting, the corporate knowledgeable that considered one of its promoters acquired 20,000 fairness shares of the corporate by means of open market transactions.
Sanjay Tibrewala, a promoter of Fineotex Chemical, has bought 20,000 fairness shares of the corporate value ₹41,31,600 by means of an open market transaction on March 6, 2025. Previous to the acquisition, Tibrewala held 34,34,900 Fineotex Chemical shares, representing 3% stake within the firm.
After the latest transaction, Tibrewala’s shareholding has elevated to 34,54,900 shares, representing 3.02% stake, as per the regulatory submitting.
In keeping with the Fineotex Chemical shareholding sample as of December 2024, Promoter & Promoter Group held 7,20,25,027 fairness shares, or 62.86% stake, within the firm, whereas the remainder 37.14% stake was owned by public shareholders.
Ashish Kacholia’s Stake in Fineotex Chemical
Ace investor Ashish Kacholia holds 31,35,568 fairness shares of Fineotex Chemical, representing 2.7% within the firm on the finish of December 2024 quarter. The entire worth of Kacholia’s funding is ₹74.8 crore.
Fineotex Chemical Inventory Value Pattern
Fineotex Chemical share worth has fallen 16% in a single month and has corrected 34% previously six months. The small-cap inventory has declined 39% in a single yr, however has delivered multibagger returns of 1,043% previously 5 years.
At 12:05 PM, Fineotex Chemical shares had been buying and selling 0.65% greater at ₹239.75 apiece on the BSE.
Disclaimer: The views and suggestions made above are these of particular person analysts or broking corporations, and never of Mint. We advise traders to examine with licensed specialists earlier than making any funding choices.
